1-4 of 4
Shalon Jones
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Fedratinib Versus Best Available Therapy on Patient-Reported Outcomes in Patients with Myelofibrosis Who Were Previously Treated with Ruxolitinib: Results from the Phase 3 FREEDOM2 Trial

Claire Harrison, Jennifer Lord-Bessen, Ling Shi, Shien Guo, Aylin Yucel, Dorothy Zissler, Shalon Jones, Samantha Slaff
Journal: Blood
Blood (2024) 144 (Supplement 1): 6624.
https://doi.org/10.1182/blood-2024-198368
Published: 2024
Journal Articles

Real-World Experience with Anemia and Iron Overload Therapies in Myelodysplastic Syndromes (MDS): Treatment Sequence, Duration, and Patient Compliance

Krystal Huey, Ruizhi Zhao, Tao Gu, Trong Kim Le, Shalon Jones, Luciana Bueno, Derek Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-136684
Published: 2020
Journal Articles

Association between Transfusion Status (TS) and Clinical and Economic Outcomes in Patients with Myelodysplastic Syndromes (MDS) from the Physicians' Perspective

Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Shaloo Gupta, Thomas Schroeder, Halley Constantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-136740
Published: 2020
Journal Articles

Physicians' Experience in Blood Supply Shortages and the Top Factors That Impact the Clinical, Economic, and Humanistic Outcomes of Myelodysplastic Syndrome (MDS) Patients in 5 European Countries

Shaloo Gupta, Thomas Schroeder, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath, Halley Constantino, Jay Grisolano, Jackson Tang, Shalon Jones, Derek Tang
Journal: Blood
Blood (2020) 136 (Supplement 1): 43–44.
https://doi.org/10.1182/blood-2020-136698
Published: 2020